Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Community builders honoured at Community Engagement Awards
2016-10-13

Description: "06 -10-2016 Comm Engagement Awards Read More Tags: Comm Engagement Awards

Photo: Charl Devenish

The office of Community Engagement held its annual Community Engagement Awards at the University of the Free State (UFS) on 5 October 2016. This year, the ceremony celebrated people who gave themselves selflessly to improve the lives of those around them who are less privileged. Key players in various sectors of society were recognised and honoured for their contribution and commitment towards a common good.

Dr Richard Teare, president of the Global University for Lifelong Learning (GULL), was the keynote speaker at the ceremony. GULL, a non-profit foundation, operates across the world, providing access to lifelong learning for communities, giving each individual an opportunity to make a difference in their world. Dr Teare talked of places that lack the provision and infrastructure to access higher education and said that through community service programmes, social and economic development was enhanced, and the necessary expertise and resources were provided to drive a community towards a greater good. “Community engagement espouses academic excellence—it enables people to discover their full potential.”

Through its partnership with GULL, the University of Free State has worked with women from Bloem Shelter, an organisation that provides assistance to underprivileged women and children from diverse walks of life. The women were equipped with the necessary skills and knowledge they needed to become self-sufficient - an experience that has yielded positive, constructive change in the women’s lives. 

The awards also acknowledged the boldness and innovative support of members of the Free State community in their various sectors. Among those awarded was Dr Choice Makhetha for her contribution in building capacity for those involved in community service programmes. She also designed and created approaches to improve situations in schools, churches, community organisations and small businesses. Also presented with an award was Dr Dipane Hlalele of the Qwaqwa Campus for his role as principal investigator in two National Research Foundation (NRF) -funded projects; Rural Relational Leadership and Sustainable Rural and Urban Connection. The ICT Innovation in School Education division of the South Campus was also recognised for its Internet Broadcast Project (IBP), which provides lessons on different subjects to 72 000 learners and 3 000 teachers each week.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept